Cancedda S, Rohrer Bley C, Aresu L et al. (2016) Efficacy and side effects of radiation therapy in comparison with radiation therapy and temozolomide in the treatment of measurable canine malignant melanoma. Veterinary and Comparative Oncology 14, 146–157

Dolera M, Malfassi L, Bianchi C et al. (2018) Frameless stereotactic radiotherapy alone and combined with temozolomide for presumed canine gliomas. Veterinary and Comparative Oncology 16, 90–101

Gagnon J, Dervisis G and Kitchell BE (2012) Treatment-related toxicities in tumor-bearing cats treated with temozolomide alone or in combination with doxorubicin: a pilot assessment. Journal of Feline Medicine and Surgery 14, 560–565

Marconato L, Bley CR, Leone VF and Finotello R (2020) An open-label dose escalation study evaluating tolerability and safety of a single 5-days course of temozolomide in dogs with advanced cancer. Veterinary and Comparative Oncology 18, 838–842

Treggiari E, Elliot JW, Baines SJ et al. (2017) Temozolomide alone or in combination with doxorubicin as a rescue agent in 37 cases of canine multicentric lymphoma. Veterinary and Comparative Oncology 16, 194–201

Urso G, Boncu AG, Carrara N et al. (2022) Cranial spinal spreading of canine brain gliomas after hypofractionated volumetric-modulated arc radiotherapy and concomitant temozolomide chemotherapy: a four-case report. Veterinary Sciences 9, 541